Versant Capital Management, Inc

Position in PAHC — Phibro Animal Health Corp

CIK 1735057 PHOENIX, AZ

Back to PAHC Full portfolio

Position in PAHC

as of Jun 30, 2026 · filed Jul 2, 2026 Compact

Position Value

$973

+$269 QoQ

Shares Held

-32.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#190

of 207 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in PAHC Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Versant Capital Management, Inc holds $2,428,042 across 29 Drug Manufacturers - Specialty & Generic names. PAHC ranks #27 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	42,686	$684,256
2	TEVA	Teva Pharmaceutical Industries Ltd	10,265	$347,778
3	ELAN	Elanco Animal Health Inc	9,055	$222,843
4	VTRS	Viatris Inc	11,789	$187,209
5	HLN	Haleon plc	16,968	$158,311
6	NBIX	Neurocrine Biosciences Inc	737	$124,213
7	UTHR	UNITED THERAPEUTICS Corp	182	$98,613
8	ZTS	Zoetis Inc.	1,244	$89,393

All Filings in PAHC

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$973	31	-32.6%	Shares	Sole	2026-07-02
2023-03-31	$704	46	0.0%	Shares	Sole	2023-04-10
2022-12-31	$616	46	-29.2%	Shares	Sole	2023-01-25
2022-09-30	$863	65	+35.4%	Shares	Sole	2022-12-30
2021-12-31	$980	48	+182.4%	Shares	Sole	2022-01-06
2021-09-30	$366	17	-76.4%	Shares	Sole	2021-10-29
2021-06-30	$2,079	72	+323.5%	Shares	Sole	2021-07-22
2020-12-31	$330	17	-92.2%	Shares	Sole	2021-02-08
2020-09-30	$3,775	217	-47.7%	Shares	Sole	2020-11-02
2020-06-30	$10,902	415	-27.4%	Shares	Sole	2020-07-16
2020-03-31	$13,825	572	—	Shares	Sole	2020-04-17
No filing history on record for this holder in this stock.